A detailed history of Solstein Capital, LLC transactions in Danaher Corp stock. As of the latest transaction made, Solstein Capital, LLC holds 175 shares of DHR stock, worth $40,337. This represents 0.02% of its overall portfolio holdings.

Number of Shares
175
Previous 244 28.28%
Holding current value
$40,337
Previous $60,000 20.0%
% of portfolio
0.02%
Previous 0.04%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$239.25 - $280.76 $16,508 - $19,372
-69 Reduced 28.28%
175 $48,000
Q4 2023

Jan 22, 2024

SELL
$185.1 - $233.13 $152,337 - $191,865
-823 Reduced 77.13%
244 $56,000
Q1 2023

Apr 19, 2023

SELL
$239.75 - $277.0 $129,225 - $149,303
-539 Reduced 33.56%
1,067 $268,000
Q4 2022

Feb 02, 2023

SELL
$241.42 - $282.29 $79,910 - $93,437
-331 Reduced 17.09%
1,606 $426,000
Q3 2022

Nov 01, 2022

BUY
$247.06 - $1507.4 $40,517 - $247,213
164 Added 9.25%
1,937 $500,000
Q1 2022

May 05, 2022

BUY
$257.27 - $315.76 $181,632 - $222,926
706 Added 66.17%
1,773 $520,000
Q2 2021

Aug 12, 2021

BUY
$225.08 - $271.69 $1,350 - $1,630
6 Added 0.57%
1,067 $286,000
Q4 2020

Feb 11, 2021

BUY
$212.5 - $245.46 $225,462 - $260,433
1,061 New
1,061 $238,000
Q3 2020

Nov 12, 2020

SELL
$177.16 - $215.33 $33,660 - $40,912
-190 Closed
0 $0
Q1 2020

May 12, 2020

SELL
$121.39 - $169.05 $310,637 - $432,598
-2,559 Reduced 93.09%
190 $26,000
Q4 2019

Feb 12, 2020

BUY
$133.47 - $153.48 $366,909 - $421,916
2,749 New
2,749 $422,000
Q1 2019

May 08, 2019

SELL
$97.62 - $132.29 $263,574 - $357,183
-2,700 Closed
0 $0
Q4 2018

Feb 04, 2019

BUY
$94.85 - $109.54 $256,094 - $295,758
2,700 New
2,700 $278,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $168B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Solstein Capital, LLC Portfolio

Follow Solstein Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Solstein Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Solstein Capital, LLC with notifications on news.